Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

CCL2 binding is CCR2 independent in primary adult human astrocytes.

Fouillet A, Mawson J, Suliman O, Sharrack B, Romero IA, Woodroofe MN.

Brain Res. 2012 Feb 9;1437:115-26. doi: 10.1016/j.brainres.2011.11.049. Epub 2011 Dec 4.

PMID:
22226505
2.

Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.

Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN.

J Neuroimmunol. 2000 Aug 1;108(1-2):192-200.

PMID:
10900353
3.

Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes.

Kuscher K, Danelon G, Paoletti S, Stefano L, Schiraldi M, Petkovic V, Locati M, Gerber BO, Uguccioni M.

Eur J Immunol. 2009 Apr;39(4):1118-28. doi: 10.1002/eji.200838906.

4.

Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.

Tanuma N, Sakuma H, Sasaki A, Matsumoto Y.

Acta Neuropathol. 2006 Aug;112(2):195-204. Epub 2006 May 30.

PMID:
16733654
6.
7.

Expression of binding sites for beta chemokines on human astrocytes.

Andjelkovic AV, Kerkovich D, Shanley J, Pulliam L, Pachter JS.

Glia. 1999 Dec;28(3):225-35.

PMID:
10559781
8.

Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.

Sabri F, Tresoldi E, Di Stefano M, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G.

Virology. 1999 Nov 25;264(2):370-84.

9.

The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.

Cochain C, Auvynet C, Poupel L, Vilar J, Dumeau E, Richart A, Récalde A, Zouggari Y, Yin KY, Bruneval P, Renault G, Marchiol C, Bonnin P, Lévy B, Bonecchi R, Locati M, Combadière C, Silvestre JS.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2206-13. doi: 10.1161/ATVBAHA.112.254409. Epub 2012 Jul 12.

10.

Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain.

Banisadr G, Quéraud-Lesaux F, Boutterin MC, Pélaprat D, Zalc B, Rostène W, Haour F, Parsadaniantz SM.

J Neurochem. 2002 Apr;81(2):257-69.

11.

Functional expression of CCR2 by human fetal astrocytes.

Andjelkovic AV, Song L, Dzenko KA, Cong H, Pachter JS.

J Neurosci Res. 2002 Oct 15;70(2):219-31.

PMID:
12271471
12.

Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.

Neumeier M, Bauer S, Brühl H, Eisinger K, Kopp A, Abke S, Walter R, Schäffler A, Buechler C.

Cytokine. 2011 Dec;56(3):573-80. doi: 10.1016/j.cyto.2011.08.017. Epub 2011 Sep 3. Erratum in: Cytokine. 2013 Jun;62(3):453.

PMID:
21890375
13.

A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.

Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, Berman JW.

J Neuroimmunol. 2006 Aug;177(1-2):27-39. Epub 2006 Jun 19.

PMID:
16782208
14.

Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

Mahad D, Callahan MK, Williams KA, Ubogu EE, Kivisäkk P, Tucky B, Kidd G, Kingsbury GA, Chang A, Fox RJ, Mack M, Sniderman MB, Ravid R, Staugaitis SM, Stins MF, Ransohoff RM.

Brain. 2006 Jan;129(Pt 1):212-23. Epub 2005 Oct 17.

PMID:
16230319
15.

Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones.

Gosselin RD, Varela C, Banisadr G, Mechighel P, Rostene W, Kitabgi P, Melik-Parsadaniantz S.

J Neurochem. 2005 Nov;95(4):1023-34. Epub 2005 Sep 7.

16.

Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.

Kalkonde YV, Morgan WW, Sigala J, Maffi SK, Condello C, Kuziel W, Ahuja SS, Ahuja SK.

Brain Res. 2007 Jan 12;1128(1):1-11. Epub 2006 Nov 28.

PMID:
17126305
17.

Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus.

Foresti ML, Arisi GM, Katki K, Montañez A, Sanchez RM, Shapiro LA.

J Neuroinflammation. 2009 Dec 24;6:40. doi: 10.1186/1742-2094-6-40.

18.

Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice.

Huang D, Wujek J, Kidd G, He TT, Cardona A, Sasse ME, Stein EJ, Kish J, Tani M, Charo IF, Proudfoot AE, Rollins BJ, Handel T, Ransohoff RM.

FASEB J. 2005 May;19(7):761-72.

PMID:
15857890
19.

CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.

Maus UA, Wellmann S, Hampl C, Kuziel WA, Srivastava M, Mack M, Everhart MB, Blackwell TS, Christman JW, Schlöndorff D, Bohle RM, Seeger W, Lohmeyer J.

Am J Physiol Lung Cell Mol Physiol. 2005 Feb;288(2):L350-8. Epub 2004 Oct 29.

PMID:
15516494
20.

Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.

Babcock AA, Kuziel WA, Rivest S, Owens T.

J Neurosci. 2003 Aug 27;23(21):7922-30.

Supplemental Content

Support Center